DPI-386 is a nasal gel version of the antimuscarinic drug scopolamine, first approved by the FDA as a transdermal patch in 1979, according to the drug’s label. Currently, patches are placed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback